Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Robert M. Williams, Jr. sold 750,000 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the transaction, the insider now owns 28,890,756 shares of the company's stock, valued at $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Aveanna Healthcare Price Performance
AVAH stock traded down $0.16 during midday trading on Friday, reaching $4.93. 65,595 shares of the company's stock traded hands, compared to its average volume of 323,940. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19. The business has a 50-day moving average price of $5.09 and a two-hundred day moving average price of $4.92. The company has a market capitalization of $960.84 million, a P/E ratio of -14.48 and a beta of 2.03.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. UBS Group upped their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday, May 9th. Truist Financial dropped their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th.
Get Our Latest Research Report on Aveanna Healthcare
Hedge Funds Weigh In On Aveanna Healthcare
A number of hedge funds have recently made changes to their positions in AVAH. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare during the 1st quarter worth $25,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Aveanna Healthcare during the 4th quarter valued at about $35,000. BNP Paribas Financial Markets acquired a new position in Aveanna Healthcare during the 4th quarter worth approximately $35,000. Tower Research Capital LLC TRC boosted its holdings in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after acquiring an additional 6,854 shares during the period. Finally, Catalyst Funds Management Pty Ltd grew its position in Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock valued at $54,000 after acquiring an additional 9,000 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
